Plain-English translation of NCT06833749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help reduce knee arthritis pain and support weight loss in people living with obesity. Researchers will compare how the medication works against a placebo (a dummy pill with no active drug) to see if it truly makes a difference. The study also looks at how the treatment affects quality of life and body metabolism.
Knee arthritis in people with obesity is challenging to treat, and current pain relief options don't work well enough for everyone. This trial exists to see if this medication can offer better pain relief and potentially help with weight management at the same time.
You likely qualify if…
You likely don't qualify if…
You will receive either the new medication or a placebo as a weekly injection for 6 months. You'll visit the clinic every 2 weeks for check-ups, blood tests, and X-rays to monitor your progress. Throughout the study, you'll keep a diary of your symptoms and any pain relief medication you use, and you'll be asked to continue diet and exercise as part of your treatment plan.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
Czechia